Antacid/H2 use in arthritis patients taking NSAIDS may exacerbate GI risk -- study.
This article was originally published in The Tan Sheet
Executive Summary
ANTACID/H2 ANTAGONIST USE IN ARTHRITIS PATIENTS TAKING NSAIDS MAY INCREASE GI RISK, according to an article in the July 22 issue of the Archives of Internal Medicine. "Prophylactic treatment with antacids and H2 receptor antagonists [to combat GI side effects that result from frequent use of nonsteroidal anti-inflammatory drugs] is of questionable value and may increase the risk for subsequent serious GI complications" in rheumatoid arthritis sufferers, Gurkipal Singh, MD, Stanford University School of Medicine, et al. reported.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning